Kintara Therapeutics (KTRA) News Today → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free KTRA Stock Alerts $0.14 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRAstockhouse.com - April 11 at 1:42 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, KTRAstockhouse.com - April 10 at 2:02 PMSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRAprnewswire.com - April 9 at 8:15 PMKINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRAbusinesswire.com - April 5 at 1:31 PMAPhA and CDC select Community of Practice Teams to advance health equity and prevent heart disease and strokefinance.yahoo.com - April 5 at 3:01 AMCrude Oil Moves Higher; ISM Services PMI Falls In Marchmarkets.businessinsider.com - April 3 at 2:24 PMWhy Kintara Therapeutics Shares Are Gaining Todaymsn.com - April 3 at 2:24 PMKTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholdersstockhouse.com - April 3 at 2:24 PMShareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURAprnewswire.com - April 3 at 1:43 PMWhy Is Kintara Therapeutics (KTRA) Stock Up 103% Today?investorplace.com - April 3 at 9:46 AMKintara Therapeutics Sets Reverse Merger With TuHURA Biosciencesmarketwatch.com - April 3 at 9:23 AMKintara Therapeutics To Merge Into TuHURA Biosciencesmarkets.businessinsider.com - April 3 at 9:23 AMKintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreementfinance.yahoo.com - April 3 at 9:23 AMmarketbeat.com - April 3 at 6:56 AMKintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumabfinance.yahoo.com - March 27 at 9:13 AMKintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumabprnewswire.com - March 27 at 9:00 AMKintara Therapeutics Bounces Backnasdaq.com - March 15 at 11:31 PMKintara Therapeutics Inc (KTRA)uk.investing.com - February 21 at 1:32 PMMyMD Pharmaceuticals Inc (0A8D)uk.investing.com - February 20 at 12:30 PMKintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - February 14 at 6:48 PMKintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Updateprnewswire.com - February 14 at 4:07 PMKintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancerfinance.yahoo.com - February 12 at 10:04 AMPanbela Therapeutics closes ~$9M public offering of sharesmsn.com - February 1 at 8:55 AMKintara Announces Review Of Strategic Alternatives To Maximize Stockholder Valuemarkets.businessinsider.com - December 7 at 11:28 AMKintara Therapeutics Announces Review of Strategic Alternativesfinance.yahoo.com - December 7 at 9:46 AMKintara Therapeutics Inc (3DMA.BE)ca.finance.yahoo.com - November 28 at 7:05 PMKintara Therapeutics Inc KTRAmorningstar.com - November 16 at 10:42 PMKintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - November 13 at 6:43 PMWhy Kintara Therapeutics (KTRA) Shares Are Getting Obliteratedbenzinga.com - November 1 at 5:51 PMKintara Therapeutics Shares Plumb New Depths on VAL-083 Failuremarketwatch.com - October 31 at 3:31 PMmarketbeat.com - October 31 at 9:35 AMKintara Says Glioblastoma Treatment Candidate Shows Little Promisemarketwatch.com - October 31 at 9:15 AMKintara Shares Down 72% After Suspending Glioblastoma Drug Developmentmarketwatch.com - October 31 at 9:15 AMKintara Therapeutics Suspends Development Of VAL-083 In Glioblastoma; Stock Dropsmarkets.businessinsider.com - October 31 at 9:15 AMmarketbeat.com - October 31 at 7:57 AMmarketbeat.com - October 26 at 9:37 AMKintara Therapeutics to Present at the 8th Annual Dawson James Small Cap Growth Conferencefinance.yahoo.com - October 11 at 8:39 AMKintara Therapeutics to Present at the LD Micro Main Event XVI Conferencefinance.yahoo.com - October 2 at 10:51 AMKintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meetingfinance.yahoo.com - September 25 at 8:57 AMKintara Therapeutics Non-GAAP EPS of -$9.27seekingalpha.com - September 19 at 10:27 PMKintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Updatefinance.yahoo.com - September 18 at 7:30 PMKTRA - Kintara Therapeutics, Inc.uk.finance.yahoo.com - September 14 at 8:06 PMKintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meetingfinance.yahoo.com - September 5 at 10:32 AMKintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023finance.yahoo.com - August 17 at 9:26 PMKintara Therapeutics to Present at the Emerging Growth Conferencefinance.yahoo.com - August 9 at 8:24 AMPresenting on the Emerging Growth Conference on August 9 & 10 Register Nowfinance.yahoo.com - August 8 at 7:19 AMBenzinga's Top Ratings Upgrades, Downgrades For July 14, 2023msn.com - July 14 at 12:49 PMKintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapyfinance.yahoo.com - June 30 at 1:27 PMKintara Therapeutics Stock Is Trading Higher: What's Driving The Action?benzinga.com - June 29 at 10:02 AMKintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001finance.yahoo.com - June 28 at 6:15 PM Get Kintara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Will this $2 AI stock double overnight? (Ad)It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share! Click here to learn more >>> KTRA Media Mentions By Week KTRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KTRA News Sentiment▼0.000.43▲Average Medical News Sentiment KTRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KTRA Articles This Week▼01▲KTRA Articles Average Week Get Kintara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PXMD News Today ALZN News Today SNPX News Today DRUG News Today GTBP News Today OGEN News Today SONN News Today NEXI News Today PTPI News Today XCUR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KTRA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kintara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
